Rashid, K.; Röder, C.; Goumas, F.; Egberts, J.-H.; Kalthoff, H.
CD95L Inhibition Impacts Gemcitabine-Mediated Effects and Non-Apoptotic Signaling of TNF-α and TRAIL in Pancreatic Tumor Cells. Cancers 2021, 13, 5458.
https://doi.org/10.3390/cancers13215458
AMA Style
Rashid K, Röder C, Goumas F, Egberts J-H, Kalthoff H.
CD95L Inhibition Impacts Gemcitabine-Mediated Effects and Non-Apoptotic Signaling of TNF-α and TRAIL in Pancreatic Tumor Cells. Cancers. 2021; 13(21):5458.
https://doi.org/10.3390/cancers13215458
Chicago/Turabian Style
Rashid, Khalid, Christian Röder, Freya Goumas, Jan-Hendrik Egberts, and Holger Kalthoff.
2021. "CD95L Inhibition Impacts Gemcitabine-Mediated Effects and Non-Apoptotic Signaling of TNF-α and TRAIL in Pancreatic Tumor Cells" Cancers 13, no. 21: 5458.
https://doi.org/10.3390/cancers13215458
APA Style
Rashid, K., Röder, C., Goumas, F., Egberts, J.-H., & Kalthoff, H.
(2021). CD95L Inhibition Impacts Gemcitabine-Mediated Effects and Non-Apoptotic Signaling of TNF-α and TRAIL in Pancreatic Tumor Cells. Cancers, 13(21), 5458.
https://doi.org/10.3390/cancers13215458